"Long-term treatment with bisphosphonates for osteoporosis hikes the chances of atypical femur fractures nearly three-fold, researchers said, but the absolute risk remains very small."
Read more: Medical News: Atypical Fracture Risk with Bone Drugs Quantified - in Endocrinology, Osteoporosis from MedPage Today:
No comments:
Post a Comment